TherapeuticsMD | TXMD - Debt


TherapeuticsMD reported $93.6M in Debt for its fiscal quarter ending in September of 2022.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Grifols EUR 9.23B 626.05M Dec/2024
Novo Nordisk DKK 118.72B 15.94B Mar/2025
Pfizer USD 60.85B 78M Sep/2025
TherapeuticsMD USD 93.6M 2.82M Sep/2022